{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:40:34Z","timestamp":1793882434534,"version":"4.7.0"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/mmy\/myx101","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T07:09:24Z","timestamp":1506496164000},"page":"S93-S101","source":"Crossref","is-referenced-by-count":472,"title":["Challenges in the diagnosis and treatment of mucormycosis"],"prefix":"10.1093","volume":"56","author":[{"given":"A","family":"Skiada","sequence":"first","affiliation":[{"name":"Laiko Hospital, National and Kapodistrian University of Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lass-Floerl","sequence":"additional","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Laboratory for Invasive Fungal Infections, Medical University of Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Klimko","sequence":"additional","affiliation":[{"name":"Department of Clinical Mycology, Allergy and Immunology, North Western State Medical University, Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, David Geffen School of Medicine, UCLA"},{"name":"Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Roilides","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, 3rd Department of Pediatrics, Faculty of Medicine, Aristotle University School of Health Sciences, Hippokration General Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Petrikkos","sequence":"additional","affiliation":[{"name":"School of Medicine, European University of Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"key":"key\n\t\t\t\t20181003023225_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mycres.2007.03.004","article-title":"A higher level phylogenetic classification of the Fungi.","volume":"111","author":"Hibbett","year":"2007","journal-title":"Mycol Res"},{"key":"key\n\t\t\t\t20181003023225_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/myc.12149","article-title":"Prospective Antifungal Therapy (PATH) Alliance(\u00ae): focus on mucormycosis","volume":"57","author":"Kontoyiannis","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20181003023225_bib5","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib6","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/myc.12243","article-title":"Mucormycosis in India: unique features","volume":"57","author":"Chakrabarti","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20181003023225_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.riam.2014.06.005","article-title":"Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).","volume":"32","author":"Chander","year":"2015","journal-title":"Rev Iberoam Micol"},{"key":"key\n\t\t\t\t20181003023225_bib9","first-page":"4428","article-title":"Primary cutaneous mucormycosis produced by the new species Apophysomyces mexicanus","volume":"52","author":"Bonifaz","year":"2014"},{"key":"key\n\t\t\t\t20181003023225_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycosis.","volume":"30","author":"Farmakiotis","year":"2016","journal-title":"Infect Dis Clinf North Am"},{"key":"key\n\t\t\t\t20181003023225_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cmi.2016.01.005","article-title":"Mucormycosis in Australia: contemporary epidemiology and outcomes","volume":"22","author":"Kennedy","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/23744235.2016.1239027","article-title":"Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections\u2014a study from a tertiary care hospital in north India","volume":"49","author":"Chander","year":"2017","journal-title":"Infect Dis (Lond)"},{"key":"key\n\t\t\t\t20181003023225_bib13","article-title":"","author":"Jeong","year":"2017"},{"key":"key\n\t\t\t\t20181003023225_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.00056-10","article-title":"Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species","volume":"24","author":"Gomes","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20181003023225_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/myc.12392","article-title":"Estimated burden of fungal infections in Germany.","volume":"58","author":"Ruhnke","year":"2015","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20181003023225_bib16","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/clinids\/27.5.1138","article-title":"The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992\u20131993: results of population-based laboratory active surveillance","volume":"27","author":"Rees","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/myc.12247","article-title":"Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia.","volume":"57","author":"Klimko","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20181003023225_bib18","article-title":"Diabetes mellitus as the major risk factor for mucormycosis in Mexico: epidemiology, diagnosis, and outcomes of reported cases","author":"Corzo-Leon","year":"2017","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20181003023225_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3767\/003158513X665539","article-title":"Taxonomy and epidemiology of Mucor irregularis, agent of chronic cutaneous mucormycosis","volume":"30","author":"Lu","year":"2013","journal-title":"Persoonia"},{"key":"key\n\t\t\t\t20181003023225_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11046-012-9559-2","article-title":"Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature","volume":"174","author":"Li","year":"2012","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t20181003023225_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12879-016-2005-1","article-title":"Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries","volume":"16","author":"Pana","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2334-14-310","article-title":"Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data","volume":"14","author":"Zilberberg","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib23","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1128\/AAC.00536-11","article-title":"Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009","volume":"55","author":"Hammond","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0970-2113.148452","article-title":"Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient","volume":"32","author":"Aggarwal","year":"2015","journal-title":"Lung India."},{"key":"key\n\t\t\t\t20181003023225_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/cit929","article-title":"The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?","volume":"58","author":"Legouge","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib27","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.cmi.2015.03.019","article-title":"Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis","volume":"21","author":"Jung","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib28","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1097\/RLU.0b013e3182867d13","article-title":"Utility of 18F- FDG PET\/CT in diagnosis and management of mucormycosis","volume":"38","author":"Liu","year":"2013","journal-title":"Clin Nucl Med"},{"key":"key\n\t\t\t\t20181003023225_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/0970-2113.201320","article-title":"Pulmonary mucormycosis diagnosed by convex probe endobronchial ultrasound-guided fine needle aspiration of cavity wall","volume":"34","author":"Nair","year":"2017","journal-title":"Lung India"},{"key":"key\n\t\t\t\t20181003023225_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5858\/2001-125-0375-HFOZ","article-title":"Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology","volume":"125","author":"Frater","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t20181003023225_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1469-0691.2009.02999.x","article-title":"Zygomycosis: conventional laboratory diagnosis","volume":"5","author":"Lass-Fl\u00f6rl","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib32","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients","volume":"45","author":"Lass-Fl\u00f6rl","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib33","first-page":"616","article-title":"Rapid detection of fungi in tissues using calcofluor white and fluorescence microscopy","volume":"108","author":"Monheit","year":"1984","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t20181003023225_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20181003023225_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20181003023225_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13693780500464930","article-title":"The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus","volume":"44","author":"Chakrabarti","year":"2006","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20181003023225_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1517\/17530050902878031","article-title":"Diagnosing invasive fungal diseases\u2014limitations of microbiological diagnostic methods","volume":"3","author":"Lass-Fl\u00f6rl","year":"2009","journal-title":"Expert Opin Med Diagn"},{"key":"key\n\t\t\t\t20181003023225_bib38","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary and disseminated mucormycosis (zygomycosis).","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/fmb.14.23","article-title":"Laboratory diagnosis of mucormycosis: current status and future perspectives","volume":"9","author":"Lackner","year":"2014","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00019606-200206000-00009","article-title":"In situ hybridization for the identification of filamentous fungi in tissue section","volume":"11","author":"Hayden","year":"2002","journal-title":"Diagn Mol Pathol"},{"key":"key\n\t\t\t\t20181003023225_bib41","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.00036-09","article-title":"Spectrum of zygomycete species identified in clinically significant specimens in the United States.","volume":"47","author":"Alvarez","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3343\/alm.2016.36.1.60","article-title":"Identification of mucorales from clinical specimens: a 4-year experience in a single institution","volume":"36","author":"Yang","year":"2016","journal-title":"Ann Lab Med"},{"key":"key\n\t\t\t\t20181003023225_bib43","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/JCM.36.11.3396-3398.1998","article-title":"Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates","volume":"36","author":"Ramani","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib44","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/JCM.02219-06","article-title":"Carbon assimilation profiles as a tool for identification of zygomycetes","volume":"45","author":"Schwarz","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/JCM.01070-11","article-title":"Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization \u201cTime of Flight\u201d analyzer-mediated mass spectrometry","volume":"50","author":"Schr\u00f6dl","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.06133-11","article-title":"Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales","volume":"50","author":"Vitale","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1699-0463.1992.tb04029.x","article-title":"Detection and quantitation of antibodies against Rhizopus by enzyme-linked immunosorbent assay","volume":"100","author":"Sandven","year":"1992","journal-title":"APMIS"},{"key":"key\n\t\t\t\t20181003023225_bib48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1128\/JCM.25.2.358-363.1987","article-title":"Electrophoretic and immunoblot analyses of Rhizopus arrhizus antigens","volume":"25","author":"Wysong","year":"1987","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/jcm.7.1.97-101.1978","article-title":"Development and evaluation of an immunodiffusion test for diagnosis of systemic zygomycosis (mucormycosis): preliminary report","volume":"7","author":"Jones","year":"1978","journal-title":"Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib50","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1182\/blood-2011-07-366526","article-title":"Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients","volume":"118","author":"Potenza","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20181003023225_bib51","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1128\/JCM.43.8.3760-3768.2005","article-title":"Identification of medically important molds by an oligonucleotide array","volume":"43","author":"Hsiao","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jdermsci.2005.01.010","article-title":"Genetic identification and detection of human pathogenic Rhizopus species, a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene","volume":"39","author":"Nagao","year":"2005","journal-title":"J Dermatol Sci"},{"key":"key\n\t\t\t\t20181003023225_bib53","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/497078","article-title":"Diagnosis of cutaneous mucormycosis due to Rhizopus microsporus by an innovative PCR-restriction fragment-length polymorphism method","volume":"41","author":"Larch\u00e9","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/JCM.44.3.805-810.2006","article-title":"Genetic identification of the main opportunistic mucorales by PCR-restriction fragment length polymorphism","volume":"44","author":"Machouart","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1469-0691.2007.01932.x","article-title":"High-affinity iron permease (FTR1) gene sequence-based molecular identification of clinically important Zygomycetes.","volume":"14","author":"Nyilasi","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib56","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1099\/jmm.0.000375","article-title":"Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples","volume":"65","author":"Springer","year":"2016","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib57","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/JCM.00917-08","article-title":"Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis","volume":"46","author":"Kasai","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib58","doi-asserted-by":"crossref","first-page":"e0179136","DOI":"10.1371\/journal.pone.0179136","article-title":"Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: epidemiology and microbiological characterization of the isolates","volume":"12","author":"Guinea","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20181003023225_bib59","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2169\/internalmedicine.56.7647","article-title":"Management of pulmonary mucormycosis based on a polymerase chain reaction (PCR) diagnosis in patients with hematologic malignancies: a report of four cases","volume":"56","author":"Ino","year":"2017","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t20181003023225_bib60","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).","volume":"22","author":"Millon","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20181003023225_bib62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1469-0691.12466","article-title":"Why is mucormycosis more difficult to cure than more common mycoses?","volume":"20","author":"Katragkou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib64","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI82744","article-title":"Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis","volume":"126","author":"Gebremariam","year":"2016","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20181003023225_bib65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib66","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/AAC.01467-08","article-title":"Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers","volume":"53","author":"Alastruey-Izquierdo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib67","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00452-07","article-title":"In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents","volume":"51","author":"Almyroudis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.riam.2010.01.006","article-title":"Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species","volume":"27","author":"Alvarez","year":"2010","journal-title":"Rev Iberoam Micol"},{"key":"key\n\t\t\t\t20181003023225_bib69","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/jac\/dks090","article-title":"Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis","volume":"67","author":"Salas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib70","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/AAC.01530-08","article-title":"In vitro activity of isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.","volume":"53","author":"Perkhofer","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib71","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1128\/JCM.00318-16","article-title":"Role of antifungal susceptibility testing in non-Aspergillus invasive mold infections","volume":"54","author":"Lamoth","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20181003023225_bib72","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/AAC.01463-09","article-title":"Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice","volume":"54","author":"Rodriguez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1469-0691.2006.01388.x","article-title":"Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence","volume":"12","author":"Netea","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib74","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1093\/cid\/cir869","article-title":"Host defenses against zygomycetes","volume":"54","author":"Roilides","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1172\/JCI71349","article-title":"CotH3 mediates fungal invasion of host cells during mucormycosis","volume":"124","author":"Gebremariam","year":"2014","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20181003023225_bib76","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","article-title":"A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response","volume":"59","author":"Ben-Ami","year":"2009","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20181003023225_bib77","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01136-07","article-title":"Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage","volume":"52","author":"Chamilos","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib78","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12236","article-title":"Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs","volume":"57","author":"Roilides","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20181003023225_bib79","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10\u00a0mg\/kg\/day) liposomal amphotericin B (L-Amb) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib80","first-page":"1","article-title":"Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections","volume":"8","author":"Wiederhold","year":"2016","journal-title":"Clin Pharmacol"},{"key":"key\n\t\t\t\t20181003023225_bib81","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/phar.1652","article-title":"Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent","volume":"35","author":"Rybak","year":"2015","journal-title":"Pharmacother"},{"key":"key\n\t\t\t\t20181003023225_bib82","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib83","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(16)00127-4","article-title":"Isavuconazole: an azole active against mucormycosis","volume":"16","author":"Roilides","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib84","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with hematologic malignancies and mucormycosis: a propensity score analysis","volume":"22:","author":"Kyvernitakis","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181003023225_bib85","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib86","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20181003023225_bib87","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox- AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib88","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.00361-09","article-title":"Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis","volume":"53","author":"Spellberg","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib89","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/428503","article-title":"Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes","volume":"191","author":"Gil-Lamaignere","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20181003023225_bib90","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12236","article-title":"Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs","volume":"57","author":"Roilides","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20181003023225_bib91","article-title":"The fungal Cyp51 inhibitor VT-1161 demonstrates in vitro synergy with tacrolimus against Aspergillus spp. and members of the order Mucorales, Abstract","volume-title":"54th Interscience Conference on Antimicrobial Agents and Chemotherapy (American Society for Microbiology)","author":"Fothergill"},{"key":"key\n\t\t\t\t20181003023225_bib92","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1128\/AAC.01437-15","article-title":"VT-1161 protects immunosuppressed mice from Rhizopus arrhizus var. arrhizus infection","volume":"59","author":"Gebremariam","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181003023225_bib93","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00390-17","article-title":"Prophylactic treatment with VT-1161 protects immunosuppressed mice from Rhizopus arrhizus var. arrhizus infection","author":"Gebremariam","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/56\/suppl_1\/S93\/25892463\/myx101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T10:50:14Z","timestamp":1659523814000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/56\/suppl_1\/S93\/4925966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":93,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2018,3,10]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myx101","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,3,10]]}}}